Urinary schistosomiasis among schoolchildren in Yemen: Prevalence, risk factors, and the effect of a chemotherapeutic intervention

Journal of the Egyptian Public Health Association

Volumn 88, Issue 3, 2013, Pages 130-136

  Al Waleedi, Ali A ^a   El Nimr, Nessrin A ^c   Hasab, Ali A ^c   Bassiouny, Hassan K ^c   Al Shibani, Latifa A ^b  

^a UNIVERSITY OF ADEN   (Yemen)

^b SANA A UNIVERSITY   (Yemen)

^c High Institute of Public Health Egypt   (Egypt)

Author keywords

Chemotherapeutic intervention; Praziquantel; Prevalence; Risk factors; Urinary schistosomiasis

Indexed keywords

ANTHELMINTIC AGENT;

ANIMAL; EPIDEMIOLOGY; HUMAN; PREVALENCE; RISK FACTOR; SCHISTOSOMIASIS HAEMATOBIA; YEMEN;

ANIMALS; ANTHELMINTICS; HUMANS; PREVALENCE; RISK FACTORS; SCHISTOSOMIASIS HAEMATOBIA; YEMEN;

EID: 84892169878     PISSN: 00132446     EISSN: 2090262X     Source Type: Journal    
DOI: 10.1097/01.EPX.0000441277.96615.96     Document Type: Article

References (34)

1. WHO. Report of the WHO informal consultation on schistosomiasis control. Geneva: WHO; 1998. p. 45.
2. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006; 368:1106-1118.
3. Ahmed BA. Two practical and cost effective methods for urinary schistosomiasis screening in Yemeni school children. Iran J Public Health 2009; 38:78-83.
4. Salah MA. Ultrasonography of urinary tract lesions caused by bilharziasis in Yemeni patients. BJU Int 2000; 86:790-793.
5. Nagi MAM. Evaluation of a programme for control of Schistosoma haematobium infection in Yemen. East Mediterr Health J 2005; 11 (5-6): 977-987.
6. Raja'a YA, Mubarak JS. Intestinal parasitosis and nutritional status in schoolchildren of Sahar district, Yemen. East Mediterr Health J 2006; 12 (Suppl 2): S189-S194.
7. WHO. Report on the regional workshop on the integrated control of soiltransmitted helminths and schistosomiasis, Cairo, Egypt 16-18 October 2000. Cairo (Egypt): EMRO.
8. Al-Shamiri AH, Al-Taj MA, Ahmed AS. Prevalence and co-infections of schistosomiasis/hepatitis B and C viruses among school children in an endemic areas in Taiz, Yemen. Asian Pac J Trop Med 2011; 4:404-408.
9. Raja'a YA, Assiragi HM, Abu Luhom AA, Mohammed ABS, Albahr MH, Ashaddadi MA, Al Muflihi AN. Schistosomes infection rate in relation to environmental factors in school children. Saudi Med J 2000; 21:635-638.
10. WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Geneva: WHO 2002. WHO Technical Report Series. No.: 912.
11. Bundy DAP, Hall A, Medley GF, Savioli L. Evaluating measures to control intestinal parasitic infections. World Health Stat Q 1992; 45 (2-3): 168-179.
12. Richards FO Jr, Hassan F, Cline BL, El Alamy MA. An evaluation of quantitative techniques for Schistosoma haematobium eggs in urine preserved with carbolfuchsin. Am J Trop Med Hyg 1984; 33:857-861.
13. WHO. The control of schistosomiasis. Second report of the WHO EXPERT COMMITTEE. Geneva: WHO 1993. Tech Rep Ser No.: 830.
14. Raja'a YA, Sulaiman SM, Mubarak JS, El-Bakri MM, Al-Adimi WH, El-Nabihi MT, et al. Some aspects in the control of schistosomosis and soil-transmitted helminthosis in Yemeni children. Saudi Med J 2001; 22:428-432.
15. Fournet F, N'Guessan NA, Cadot E. Land-use and urinary schistosomiasis in Daloa (Côte d'Ivoire). Bull Soc Pathol Exot 2004; 97:33-36.
16. Satayathum SA, Muchiri EM, Ouma JH, Whalen CC, King CH. Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program. Am J Trop Med Hyg 2006; 75:83-92.
17. Kapito-Tembo AP, Mwapasa V, Meshnick SR, Samanyika Y, Banda D, Bowie C, Radke S. Prevalence distribution and risk factors for Schistosoma haematobium infection among school children in Blantyre, Malawi. PLoS Negl Trop Dis 2009; 3:art. no. e361.
18. Ugbomoiko US, Obiezue RNN, Ogunniyi TAB, Ofoezie IE. Diagnostic accuracy of different urine dipsticks to detect urinary schistosomiasis: a comparative study in five endemic communities in Osun and Ogun States, Nigeria. J Helminthol 2009; 83:203-209.
19. Houmsou RS, Amuta EU, Sar TT. Profile of an epidemiological study of urinary schistosomiasis in two local government areas of Benue state, Nigeria. Int J Med Biomed Res 2012; 1:39-48.
20. Adeyeba OA, Ojeaga SGT. Urinary schistosomiasis and concomitant urinary tract pathogens among schoolchildren in metropolitan Ibadan, Nigeria. Afr J Biomed Res 2002; 5:103-107.
21. Ugbomoiko US, Ofoezie IE, Okoye IC, Heukelbach J. Factors associated with urinary schistosomiasis in two peri-urban communities in south-western Nigeria. Ann Trop Med Parasitol 2010; 104:409-419.
22. Noman MA, Alshargby SA, Kadi HO, Mansoor T, Rahman RA, Abudo GS, et al. Spread of internal parasites among the student of Al-Shaheed Al-Noman school, Widi Jadeed villages, Taiz province-Republic of Yemen. Continental J Biomed Sci 2012; 6:18-24. Available at: http://www.wilolud journal.com/ojs/index.php/ cjBioMed/article/viewFile/746/pdf-296.
23. Gazzinelli A, Velasquez-Melendez G, Crawford SB, LoVerde PT, Correa-Oliveira R, Kloos H. Socioeconomic determinants of schistosomiasis in a poor rural area in Brazil. Acta Trop 2006; 99 (2-3): 260-271.
24. Al-Shibani LA. Development of schistosomal school-based health education model for Yemeni school children [PhD thesis]. Alexandria: Alexandria University; 2003.
25. Deribe K, Eldaw A, Hadziabduli S, Kailie E, Omer MD, Mohammed AE, et al. High prevalence of urinary schistosomiasis in two communities in South Darfur: implication for interventions. Parasit Vectors 2011; 4:14.
26. Fenwick A. Waterborne infectious diseases-could they be consigned to history? Science 2006; 313:1077-1081.
27. Fenwick A, Savioli L, Engels D, Bergquist NR, Todd MH. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 2003; 19:509-515.
28. Touré S, Zhang Y, Bosqué-Oliva E, Ky C, Ouedraogo A, Koukounari A, et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ 2008; 86:780-787.
29. Nkengazong L, Njiokou F, Teukeng F, Enyong P, Wanji S. Reassessment of endemicity level of urinary schistosomiasis in the Kotto-Barombi focus (South West Cameroon) and impact of mass drug administration (MDA) on the parasitic indices. J Cell Anim Biol 2009; 3:159-164.
30. Davis A. Clinical trials in parasitic diseases. Trans R Soc Trop Med Hyg 2004; 98:139-141.
31. Koukounari A, Gabrielli AF, Touré S, Bosqué-Oliva E, Zhang Y, Sellin B, et al. Schistosoma haematobium infection and morbidity before and after largescale administration of praziquantel in Burkina Faso. J Infect Dis 2007; 196:659-669.
32. Augusto G, Magnussen P, Kristensen TK, Appleton CC, Vennervald BJ. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique. Parasitology 2009; 136:1771-1779.
33. Oniya OM, Jeje O. Urinary schistosomiasis: efficacy of praziquantel and association of the ABO blood grouping in disease epidemiology. Int J Biotechnol Mol Biol Res 2010; 1:31-35.
34. Ologunde CA, Olaoye AB, Olaifa OA, Olowu OY. Schistosomiasis in Ogbese-Ekiti, re-infection after successful treatment with Praziquantel. Global J Med Res 2012; 12:31-36.